Portage Biotech (Portage Biotech) Total Assets : $49.04 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Portage Biotech Total Assets?

Portage Biotech's Total Assets for the quarter that ended in Dec. 2023 was $49.04 Mil.

During the past 12 months, Portage Biotech's average Total Assets Growth Rate was -77.90% per year. During the past 3 years, the average Total Assets Growth Rate was -19.50% per year. During the past 5 years, the average Total Assets Growth Rate was 67.50% per year. During the past 10 years, the average Total Assets Growth Rate was 93.90% per year.

During the past 13 years, Portage Biotech's highest 3-Year average Total Assets Growth Rate was 488.90%. The lowest was -81.70%. And the median was 5.20%.

Total Assets is connected with ROA %. Portage Biotech's annualized ROA % for the quarter that ended in Dec. 2023 was -222.71%. Total Assets is also linked to Revenue through Asset Turnover. Portage Biotech's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Portage Biotech Total Assets Historical Data

The historical data trend for Portage Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portage Biotech Total Assets Chart

Portage Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Assets

Get a 7-Day Free Trial

173.72

173.17

174.86

194.66

99.13

Portage Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															210.68	99.13	98.37	92.40	49.04

Portage Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Portage Biotech's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (A: Mar. 2023 )	+	Total Liabilities (A: Mar. 2023 )
	=	75.395	+	23.734
	=	99.13

Portage Biotech's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	31.33	+	17.705
	=	49.04

Portage Biotech (NAS:PRTG) Total Assets Explanation

Total Assets is connected with ROA %.

Portage Biotech's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-157.492	/	( (92.4	+	49.035)	/ 2 )
	=	-157.492	/	70.7175
	=	-222.71 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Portage Biotech's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (92.4	+	49.035)	/ 2 )
=	0	/	70.7175
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Portage Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Portage Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Portage Biotech (Portage Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portage Biotech Inc (NAS:PRTG) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clarence Thomas Building, P.O. Box 4649, Tortola, Road Town, VGB, VG1110

Website

https://www.portagebiotech.com

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.